To Cure or Kill
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
To Cure or Kill
Acheter pour 22,40 €
Aucun moyen de paiement n'est renseigné par défaut.
Désolés ! Le mode de paiement sélectionné n'est pas autorisé pour cette vente.
-
Lu par :
-
Michael Young
-
M. D.
-
De :
-
Michael Young
À propos de cette écoute
The pharmaceutical industry applies evolving scientific knowledge to create new drugs and potential life-saving therapies. Pharmaceutical companies also reap significant financial gains from their drug and therapeutic developments. This monetary incentive could potentially result in aggressive inter-pharmaceutical company espionage.
In this novel, a profiteering pharmaceutical executive seizes upon an opportunity to turn the discovery of a new cancer-preventing drug into a massive industry-competitive advantage for his company and his own personal financial gain. Using ruthless individuals with deadly skills and intent, the executive tries to nefariously obtain the necessary molecular synthesis protocol to create the next generation of oncologic drugs. Through a detailed medical and scientific investigation, doctors, scientists, and law enforcement agencies work together to quickly understand and identify what is occurring in the shadows.
This is a frightening story of scientific discovery versus greed and the quest for money. At the end of the audiobook, the listeners will need to ask themselves the underlying question: Is this story really fiction?
©2023 GMBOOKS (P)2023 GMBOOKS
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !
